A New Combination Therapy Utilizing Mitochondria-Targeting Small-Molecule Ligands and Clinical Inhibitors against Melanoma
ACS Chemical Biology · 2026
DOI: 10.1021/acschembio.5c00562 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Biology, 2026. Verfasst von Ka-Hin Chan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Kowloon, Hung Hom, Hong Kong SAR 999077, P.R. China. Hauptthemen laut MEDLINE: Melanoma, Mitochondria, Antineoplastic Agents, Small Molecule Libraries. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Research Grants Council, University Grants Committee, National Natural Science Foundation of China, Hong Kong Polytechnic University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Kowloon, Hung Hom, Hong Kong SAR 999077, P.R. China.
- The Hong Kong Polytechnic University Shenzhen Research Institute, Shenzhen 518057, P. R. China.
- Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical Uni…
ORCID-Profile: Bo-Xin Zheng, Wing-Leung Wong
Förderung
- Research Grants Council, University Grants Committee
- National Natural Science Foundation of China
- Hong Kong Polytechnic University
Zitieren
APA
Chan, K. H., Zheng, B. X., Zheng, Y., Zheng, W. D., Zeng, Y. X., Long, W., Zhang, S., Hou, N., Yuan, W., & Wong, W. L. (2026). A New Combination Therapy Utilizing Mitochondria-Targeting Small-Molecule Ligands and Clinical Inhibitors against Melanoma. ACS Chemical Biology. https://doi.org/10.1021/acschembio.5c00562
Vancouver
Chan KH, Zheng BX, Zheng Y, Zheng WD, Zeng YX, Long W, et al. A New Combination Therapy Utilizing Mitochondria-Targeting Small-Molecule Ligands and Clinical Inhibitors against Melanoma. ACS Chemical Biology. 2026. doi:10.1021/acschembio.5c00562
BibTeX
@article{Chan2026,
author = {Chan, Ka-Hin and Zheng, Bo-Xin and Zheng, Yingying and Zheng, Wen-De and Zeng, Yao-Xun and Long, Wei and Zhang, Siyu and Hou, Ning and Yuan, Wenchang and Wong, Wing-Leung},
title = {A New Combination Therapy Utilizing Mitochondria-Targeting Small-Molecule Ligands and Clinical Inhibitors against Melanoma},
journal = {ACS Chemical Biology},
year = {2026},
doi = {10.1021/acschembio.5c00562}
}
EUVIMED